<DOC>
	<DOCNO>NCT01679314</DOCNO>
	<brief_summary>The study assess treatment patient Chronic Obstructive Pulmonary Disease ( COPD ) stage III IV self administer AlphaCore stimulation three time day course 2 month . Patients either receive active AlphaCore device Sham device two month know device provide . At end two month , patient ask continue study another 2 month self administer active AlphaCore device . Subjects complete diary home breathing quality life return clinic monthly assessment investigator .</brief_summary>
	<brief_title>Study Compare ( COPD ) Assessment Test COPD Stage III IV Prophylactic Treatment</brief_title>
	<detailed_description>PERFORMANCE AND SAFETY VARIABLES : The primary efficacy endpoint study total Chronic obstructive pulmonary disease ( COPD ) Assessment Test ( CAT ) score change baseline 8 week follow-up period compare two device group . Secondary efficacy endpoint mean difference baseline 8 week follow-up follow assessment : Medical Research Council ( MRC ) dyspnoea scale , 6 minute walk test Forced Expiratory Volume one second ( FEV1 ) Safety Variables : Each subject assess throughout study Adverse Events last visit ( 4 month ) subject undergo another physical examination include vital sign blood pressure .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Age 4075 year Diagnosed Chronic obstructive pulmonary disease ( COPD ) stage III IV accord Global Initiative chronic obstructive lung disease ( GOLD ) guideline Forced expiratory volume one second ( FEV 1 ) &lt; 50 % Forced expiratory volume one second ( FEV1/Forced expiratory vital capacity ( FVC ) &lt; 70 % Signed informed consent form Participation clinical trial ( drug medical device ) 30 day prior start study Subject unable comply procedure protocol study reason judge Investigator could interfere study assessment followup Has abscess infection lesion ( include lymphadenopathy ) AlphaCoreÂ® treatment site . Is currently implanted electrical and/or neurostimulator device , include limited cardiac pacemaker , defibrillator , vagal neurostimulator , deep brain stimulator , spinal stimulator , bone growth stimulator , cochlear implant . Has history carotid endarterectomy vascular neck surgery right side . Right side bilateral vagotomy Has recent repeat history syncope . Has recent repeat history seizure . Pregnant breast feeding woman</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>vagus nerve stimulation</keyword>
	<keyword>vagal nerve stimulation</keyword>
	<keyword>nVNS</keyword>
	<keyword>VNS</keyword>
	<keyword>non invasive</keyword>
	<keyword>gammacore</keyword>
</DOC>